Today

Agents

Chat

Arena

Discover

More

App

Capricor Therapeutics raises to Buy rating at JonesTrading

CAPR•2026-11-12

JonesTrading raised its rating on Capricor Therapeutics to Buy.

Related News

T

T. Rowe Price holds 3.02% of Qiagen voting rights

TROW•2026-11-12

Sempra declares quarterly dividend of $0.6575 per share

SRE•2026-11-11

Investcorp Credit Management BDC adviser waives all quarterly management fees

ICMB•2026-11-11

Prairie Operating publishes update to financial calendar

PROP•2026-11-11

Holcim subsidiary submits updated prospectus for Cementos Pacasmayo offer

HLMN•2026-11-12

Capricor Therapeutics raises to Buy rating at JonesTrading - CAPR News | Rallies